Summary
Gilead Sciences, Inc. (GILD) announced on March 3, 2008, a material definitive agreement for an accelerated share repurchase (ASR) program with Goldman Sachs & Co. This transaction involves up to $500 million of the company's common stock and is part of a larger $3 billion repurchase program previously authorized by the board. The ASR program is structured as a "collared" transaction. Gilead will pay $500 million on March 5, 2008. In return, Goldman Sachs will initially deliver approximately 7.2 million shares, representing about 75% of the minimum anticipated repurchase, on the same day. The final number of shares repurchased will be determined based on the volume-weighted average share prices over a specified period, with a minimum and maximum number of shares set by the agreement. The company expects to receive the balance of the shares no later than June 25, 2008, and these repurchased shares will be retired.
Key Highlights
- 1Gilead Sciences entered into an accelerated share repurchase (ASR) agreement for up to $500 million.
- 2The ASR transaction is part of a previously announced $3 billion share repurchase program.
- 3The company will pay $500 million to Goldman Sachs on March 5, 2008.
- 4Goldman Sachs will initially deliver approximately 7.2 million shares (around 75% of the minimum expected repurchase) on March 5, 2008.
- 5The final number of shares repurchased will be determined by the volume-weighted average share prices during a specified period.
- 6The ASR agreement includes provisions for a minimum and maximum number of shares to be repurchased.
- 7Repurchased shares under this program will be retired.